Skip to main content
Log in

Binding of teicoplanin to human serum albumin

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The interaction between the main components of the new glycopeptide antibiotic teicoplanin, A2–2, A2–3, A2–4, A2–5 and A3–1, and human serum albumin has been studied in vitro by equilibrium dialysis (pH 7.4, 37°C).

From Scatchard analysis of the data, the calculated association constants (Ka) were: A2–2, 2.47×104, A2–3, 2.86×104, A2–4, 2.95×104 and A2–5, 3.87×104 mol·l−1. The number of binding sites per albumin molecule ranged between 1.23 to 1.31. A3–1 had a lower affinity with a Ka of about 5×103 mol·l−1.

Extrapolated to the in vivo situation, the data suggested that about 90–95% of A2 components will be bound to serum albumin, and about 68–72% of A3–1.

The in vitro findings were confirmed by a pharmacokinetic study in volunteers given [14C] teicoplanin i.v., in whom the fraction of teicoplanin bound to serum protein ranged between 87.6 and 90.8%.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bardone MR, Paternoster M, Coronelli C (1978) Teichomycins, new antibiotics from Actinoplanes teichomyceticus nov. sp. II: Extraction and chemical characterization. J Antibiot 31: 170–177

    Google Scholar 

  2. Parenti F, Beretta G, Berti M, Arioli V (1978) Teichomycins, new antibiotics from Actinoplanes teichomyceticus nov. sp. I: Description of the producer strain, fermentation studies and biological properties. J Antibiot 31: 276–283

    Google Scholar 

  3. Pallanza R, Berti M, Goldstein BP, Mapelli E, Randisi E, Scotti R, Arioli V (1983) Teichomicyn in vitro and in vivo evaluation in comparison with other antibiotics. J Antimicrob Chemother 11: 419

    Google Scholar 

  4. Bauernfeind A, Petermuller C (1982) In vitro activity of teichomycin A2 in comparison with penicillin and vancomycin against Gram positive cocci. Eur J Clin Microbiol 1: 278–281

    Google Scholar 

  5. Galanakis N, Giamarellou H, Avlami A, Kanella Kopoulon K, Deudrinos Ch, Daikos GK (1985) Clinical microbiological and kinetic evaluation of teicoplanin. Chemother 4 [Suppl 2]: 682–683

    Google Scholar 

  6. Somma S, Gastaldo L, Corti A (1984) Teicoplanin a new antibiotic from Actinoplanes teichomiceticus nov. sp. Antimicrob Agents Chemother 26: 917–923

    Google Scholar 

  7. Cynamon MH, Granato PA (1982) Comparison of the in vitro activities of teichomycin A2 and vancomycin against staphylococci and enterococci. Antimicrob Agents Chemother 21: 504–505

    Google Scholar 

  8. Peters G, Pulverer G (1983) Antibacterial activity of teychomycin, a new glycopeptide antibiotic, in comparison to vancomycin. J Antimicrob Chemother 11: 94–95

    Google Scholar 

  9. Barna CJJ, Williams DH, Stone DJM, Leung TWC, Doddrell DM (1984) Structure elucidation of the teicoplanin antibiotics. J Am Chem Soc 106: 4895–4902

    Google Scholar 

  10. Traina GL, Bonati M (1984) Pharmacokinetics of teicoplanin in man after intravenous administration. J Pharmacokinet Biopharm 12: 119–128

    Google Scholar 

  11. Verbist L, Tjandramaga B, Hendrickx B, Van Hecken A, Van Melle P, Verbesselt R, Verhaegen J, De Schepper PJ (1984) In vitro activity and human pharmacokinetics of teicoplanin. Antimicrob Agents Chemother 26: 881–886

    Google Scholar 

  12. Weder HG, Schildknecht J, Kesserling P (1971) A new equilibrium dialysing system. Am Lab 10: 15–23

    Google Scholar 

  13. Scatchard G (1974) The attractions of proteins for small molecules and ions. Ann NY Acad Sci 226: 293–304

    Google Scholar 

  14. Keen P (1971) Effect of binding to plasma proteins on the distribution activity and elimination of drugs. In: Brodie B, Gillette JR (eds) Handbook of experimental pharmacology vol 28. Concepts in biochemical pharmacology. Springer, Berlin Heidelberg, pp 213–233

    Google Scholar 

  15. Gillette JR (1971) Factors affecting drug metabolism. Ann NY Acad Sci 179: 43

    Google Scholar 

  16. Gibaldi M, Perrier D (1982) Clearance concepts. In: Gibaldi M, Perrier D (eds) Drugs and the pharmaceutical sciences, vol 15. Pharmacokinetics. Marcel Dekker, NY Basel, pp 319–353

    Google Scholar 

  17. Martin BK (1965) Potential effect of the plasma proteins on drug distribution. Nature 207: 274–278

    Google Scholar 

  18. McNulty CAM, Garden GMF, Wise R, Andrews JM (1985) The pharmacokinetics and tissue penetration of teicoplanin. J Antimicrob Chemother 16: 473–749

    Google Scholar 

  19. Krogstad DJ, Moellering RC, Greenblatt DJ (1980) Single-dose kinetics of intravenous vancomycin. J Clin Pharmacol 20: 197–201

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Assandri, A., Bernareggi, A. Binding of teicoplanin to human serum albumin. Eur J Clin Pharmacol 33, 191–195 (1987). https://doi.org/10.1007/BF00544566

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00544566

Key words

Navigation